{"basic_info": {"ticker": "603259", "exchange": "XSHG", "bloomberg_ticker": "603259 CH Equity", "name": "WUXI APPTEC CO LTD-A", "industry": "Life Sciences Tools & Services", "name_chinese_simplified": "药明康德", "period": "2020", "market_value": 318687019008, "total_income": 16535431465, "ccy": "人民币元", "shariah_compliance_summary": "compliant"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 16513326640, "business_income_over_total_income": 0.99866318426303}, {"shariah_compliance": "unknown", "income": 22104822, "business_income_over_total_income": 0.0013368155555413565}], "details": [{"business_activity_cn": "中国区实验室服务", "business_activity_en": "Laboratory services in China", "income": 8545824114, "business_income_over_total_income": 0.5168189370860181, "shariah_compliance": "compliant"}, {"business_activity_cn": "美国区实验室服务", "business_activity_en": "US District Laboratory Services", "income": 1516596677, "business_income_over_total_income": 0.0917179984211558, "shariah_compliance": "compliant"}, {"business_activity_cn": "临床研究及其他CRO服务", "business_activity_en": "CRO clinical research and other services", "income": 1168852242, "business_income_over_total_income": 0.07068773769067174, "shariah_compliance": "compliant"}, {"business_activity_cn": "小分子新药工艺研发及生产业务", "business_activity_en": "Small molecule drug development process and production business", "income": 5282053607, "business_income_over_total_income": 0.31943851106518434, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他业务", "business_activity_en": "Other business", "income": 22104822, "business_income_over_total_income": 0.0013368155555413565, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.009662436440702785, "shariah_compliance": "compliant", "amount_over_market_value": 0.009662436440702785}]}